Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Saved in:
| Title: | Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area. |
|---|---|
| Authors: | Avallone, Gianluca1,2 (AUTHOR) gianluca.avallone2@gmail.com, Margiotta, Flavia Manzo3,4 (AUTHOR), Bombelli, Andrea1,2 (AUTHOR), Gargiulo, Luigi5,6 (AUTHOR), Foti, Caterina7 (AUTHOR), Trave, Ilaria8 (AUTHOR), Rossi, Mariateresa9 (AUTHOR), Magnaterra, Elisabetta10,11 (AUTHOR), Pigliacelli, Flavia12 (AUTHOR), Malagoli, Piergiorgio13 (AUTHOR), Giacalone, Serena14 (AUTHOR), Portarapillo, Antonio15 (AUTHOR), Patruno, Cataldo16 (AUTHOR), Schettini, Natale17 (AUTHOR), Bonzano, Laura18 (AUTHOR), Pezzolo, Elena19 (AUTHOR), Chello, Camilla20 (AUTHOR), Gori, Niccolò21,22 (AUTHOR), Brunasso, Giovanna23 (AUTHOR), Veronese, Federica24 (AUTHOR) |
| Source: | Dermatology & Therapy. Jul2026, p1-7. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
